Skip to content

Total debt at other companies

MYR Group logo
MYR GroupMYRG
$61.52M-53.5%
SSR Mining logo
SSR MiningSSRM
$68.42M-30.0%
Piper Sandler logo
Piper SandlerPIPR
$112.22M-3.0%
Repligen logo
RepligenRGEN
$687.62M+346%
LKQ logo
LKQLKQ
$1.49B-3.9%
EPR Properties logo
EPR PropertiesEPR
$3.13B+4.0%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

Plus components not separately reported this period.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total debt?
Generate Biomedicines, Inc. (GENB) reported total debt of $65.57M in Q1 2026.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.